BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15498766)

  • 1. Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9.
    O'Neil CH; Boffa MB; Hancock MA; Pickering JG; Koschinsky ML
    J Biol Chem; 2004 Dec; 279(53):55187-95. PubMed ID: 15498766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells.
    Romagnuolo R; DeMarco K; Scipione CA; Boffa MB; Koschinsky ML
    Thromb Res; 2018 Sep; 169():1-7. PubMed ID: 29990619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L; Boffa MB; Koschinsky ML
    PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of wild-type (Trp72) and mutant (Arg72) apolipoprotein(a) kringle IV-10 on the proliferation of human arterial smooth muscle cells.
    Yu H; Hong J; Wang B; Peng F; Li X; He C
    Chin Med J (Engl); 2003 May; 116(5):721-6. PubMed ID: 12875689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
    Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
    Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.
    Sandmark J; Tigerström A; Akerud T; Althage M; Antonsson T; Blaho S; Bodin C; Boström J; Chen Y; Dahlén A; Eriksson PO; Evertsson E; Fex T; Fjellström O; Gustafsson D; Herslöf M; Hicks R; Jarkvist E; Johansson C; Kalies I; Karlsson Svalstedt B; Kartberg F; Legnehed A; Martinsson S; Moberg A; Ridderström M; Rosengren B; Sabirsh A; Thelin A; Vinblad J; Wellner AU; Xu B; Östlund-Lindqvist AM; Knecht W
    J Biol Chem; 2020 Apr; 295(15):5136-5151. PubMed ID: 32132173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms.
    Riches K; Franklin L; Maqbool A; Peckham M; Adams M; Bond J; Warburton P; Feric NT; Koschinsky ML; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1776-83. PubMed ID: 23726972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
    Feric NT; Boffa MB; Johnston SM; Koschinsky ML
    J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a).
    Lamanuzzi LB; Mtairag el M; Pepe G; Anglés-Cano E
    Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3.
    Liu L; Craig AW; Meldrum HD; Marcovina SM; Elliott BE; Koschinsky ML
    Biochem J; 2009 Mar; 418(2):325-36. PubMed ID: 18821851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of human smooth muscle cells promoted by lipoprotein(a).
    Grainger DJ; Kirschenlohr HL; Metcalfe JC; Weissberg PL; Wade DP; Lawn RM
    Science; 1993 Jun; 260(5114):1655-8. PubMed ID: 8503012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a), plasmin modulation, and atherogenesis.
    Harpel PC; Hermann A; Zhang X; Ostfeld I; Borth W
    Thromb Haemost; 1995 Jul; 74(1):382-6. PubMed ID: 8578490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
    Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.